MAFLD: What Is It?

Houston Methodist

D. Victor

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

Pharmacologic Management of Alcohol Use Disorder

Scripps Health

R. Lee

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Alcohol Use Disorder (2024)

UCSF School of Medicine

T. Defries

Updates in Management for Patients with Cirrhosis

Duke Health

R. Doshi

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Alcoholism is a Mid-brain Disease: Treat it as Such

Houston Methodist

H. Wetsman

MASLD for the Non-Hepatologist: Insights from ADA Guidelines

Washington University in St. Louis

K. Williams

New Therapy for Fatty Liver Disease

Washington University in St. Louis

K. Korenblat

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

AI-assisted Digital Pathology in MASH Trials

Houston Methodist

V. Ratziu

Alcohol-Associated Liver Disease and MetALD

8th Annual Liver Conference

M. Mitchell

Understanding GLP-1 Agonists: Mechanisms, Efficacy, Safety, and Acce…

National Jewish Health

J. Milliron

MASLD Updates Early 2025

Adrian Lindsey

Caring for the Post Liver Transplant Patient in the Primary Care Set…

University of Colorado Department of Medicine

B. Henderson, M. O'Meara

Metabolic Endoscopy: New Approaches to Treat Obesity, Diabetes, & MA…

Cleveland Clinic - Digestive Disease Institute

A. Schulman

Fatty Liver Disease: When to Refer?

Yale School of Medicine

GI and Hepatic Complications of Cancer Immunotherapy

Michigan Medicine

R. Fontana

NAFLD: Updates in Management

UChicago Medicine

M. E. Rinella